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ABSTRACT 
 
Several studies have shown that when a human host harbours two or more strains of E. 
coli, the second strain is significantly more likely to be a member of the same phylogroup 
than to be a member of a different phylogroup.  Such an outcome may be the 
consequence of a within host evolution event or due an independent 
immigration/establishment event.  To determine the relative importance of these two 
types of events in determining E. coli diversity in a host, a large collection of E. coli that 
consisted of up to 100 isolates recovered from each of 69 patients undergoing 
colonoscopies was used.  Whole genome sequence data was available for 174 isolates 
selected to represent one example of every REP-fingerprint type identified in a patient. 
 
Sequence type characterisation and single-nucleotide polymorphism analysis revealed 
that 83% of the strains observed in the host population were a consequence of 
immigration/establishment events.  Restricting the analysis to those hosts harbouring 
two or strains belonging to the same phylogroup revealed that in about half of these 
cases the presence of a second strain belonging to the same phylogroup was the 
consequence of an independent immigration/establishment event.  Single nucleotide 
polymorphism analysis coupled with the assumption of a mutation rate of 1.1 
nucleotides/year indicated a residence time for those strains inferred to have evolved 
within the host of 1.2 years and a maximum estimated residence time of 11 years. 
 
This study has shown that when a host harbours two strains of the same phylogroup, 
then in about half of such cases, this is due to the immigration and establishment of 
strains and not within host evolution.  Thus, the results of this study show that despite 
hosts being regularly exposed to a diversity of E. coli through the food that they eat, 
factors related to the host, at least in part, determines what E. coli strains succeed in 
establishing. 
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1.1 Gut microbiome of humans 
The gut microbiome consists of a diverse assemblage of bacteria and 
bacteriophage (Gorbach, S.  L., 1996; Blottiere et al., 2013; Candela et al., 2010).  The 
gut microbiota consists of more than 500 bacterial species and these diverse 
populations of bacteria play a significant role in human health (Eckburg et al., 2005; 
Dore and Blottiere, 2015; Zhang et al., 2015).  For example, gut bacteria produce 
butyrate, the main energy source of colonocytes, and synthesize vitamin K, which we 
can’t accomplish on our own.  The gut bacteria may also promote barrier integrity, and 
prevent microbial pathogens from entering the mucosal layer (Zhang et al., 2015).  As 
well, the gut microbiota has the ability to digest substrates such as cellulose, which 
humans are incapable of digesting on their own, and as a consequence, the gut 
microbiota plays important role in determining the host’s energy intake.  The gut 
microbiome has been implicated in obesity (Turnbaugh et al., 2006), as well as many 
other conditions, including diabetes (Paun et al., 2017), inflammatory bowel 
disease (Kostic et al., 2014), and colon cancer (Vogtmann et al., 2016; Sobhani et 
al., 2013). 
 
Metagenomic analysis of total faecal DNA showed that bacterial genes make up 99% of 
the normal gut microbiome, with genes from viruses and fungi making up the remaining 
1% (Qin et al., 2010; Zhang et al., 2015).  Bacteria are taxonomically classified into four 
phyla: Bacteroidetes, Firmicutes, Actinobacteria and Proteobacteria.  Cells of species 
belonging to Bacteroidetes and Firmicutes represent 95% of the microbial 
biomass.  Microbial diversity and density increase along the gastrointestinal tract, from 
the stomach to colon (Zoetendal et al., 2008), with each region containing different 
species and concentrations of bacterial cells (Tiihonen et al., 2010).  Few bacteria 
(Helicobacter pylori etc.) can survive the acidic conditions of the stomach and upper 
small intestine, and bacterial cell densities are relatively low (103-104 bacterial cells/g of 
contents) compared to the lower small intestine (103-104 bacterial cells/g), and colon 
(1010-1012 bacterial cells/g) which contains the most diverse community of 
bacteria (Zhang et al., 2015; Tiihonen et al., 2010).  The inability of many bacteria to 
survive in the stomach and upper small intestine is likely due to the more favourable pH 
in the lower small intestine (pH 6-7.5) and colon (pH 5-7) compared to these regions (pH 
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1-3), and the absence of large amounts of bicarbonate, digestive enzymes, proteases, 
lipases, and bile, which are secreted in the upper small gut.  The colon also has a slower 
transit time than the small intestine (Gordon et al., 2015).  All of these factors result in 
different gut regions harbouring distinct bacterial species.  
  
1.2 Escherichia coli in the gastrointestinal tract 
E. coli belongs to the phylum Proteobacteria, family Enterobacteriaceae, and comprises 
approximately 0.1% of the microbial mass in healthy humans.  E. coli are gram-negative, 
non-sporulating, facultative anaerobes that inhabit the lower gastrointestinal tract and 
faeces of warm-blooded animals, birds, and reptiles (Tenaillon et al., 2010; Gordon and 
Cowling, 2003; Smati et al., 2015).  
 
E. coli is the most studied prokaryotic organism.  The species is easily grown in the 
laboratory and is often used for recombinant DNA work.  E. coli cells do not survive long 
outside a host making them an ideal faecal contamination indicator (Boehm and 
Sassoubre, 2014).  In 1884, the German-Austrian pediatrician, Theodor Escherich, 
discovered E. coli in the stool of healthy patients.  He suggested that E. coli colonises the 
gastrointestinal tract of humans 4-18 hours after birth (Alm et al., 2011). 
 
E. coli resides in the mucus layer covering the intestinal epithelial barrier, which provides 
it with nutrients to grow and divide (Tenaillon et al., 2010).  The diversity, population 
dynamics, and cell densities of E. coli within the gastrointestinal tract depends on host 
size, gut morphology, gut dynamics, diet, the wider microbial community (O’Brien & 
Gordon, 2011), and the dominant strain of E. coli present (Gordon et al., 2015; Ley et 
al., 2008; Tenaillon et al., 2010).  E. coli is more likely to be isolated from mammals than 
from birds, as well as from larger rather than from smaller hosts, and is less likely to be 
isolated from carnivores compared to herbivores or omnivores (Gordon and Cowling, 
2003). 
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1.3 Clinical importance 
Although E. coli comprises a small percentage of the total gut microbiota, it has a 
significant role in human health (Donnenberg, 2002).  E. coli is the ideal candidate to 
study commensalism and pathogenicity, because while most strains are commensal, 
some strains cause disease, resulting in approximately two million deaths per 
year (Tenaillon et al., 2010; Massot et al., 2016).  Pathogenic strains of E. coli can cause 
serious food poisoning in humans through the release of toxins, while others result in 
extra-intestinal manifestations.  E. coli are responsible for the majority (~90%) of urinary 
tract infections (UTI) (Johnson et al., 2003), and may also cause peritonitis, neonatal 
meningitis, mastitis, pneumonia, septicemia, and other infections (Johnson and Russo, 
2002).  The ability of a strain to cause disease depends mainly on its virulence properties, 
which elicit a host immune response, and include antigens (O, K, and H antigen), toxins, 
and adhesins. 
 
E. coli has distinct pathovars which cause disease.  Those pathovars are broadly classified 
into diarrhoeagenic or extraintestinal E. coli (ExPEC) (Croxan and Finlay, 2010).  These 
pathovars are sub-classified into enteropathogenic E. coli (EPEC), enterohaemorrhagic 
E. coli (EHEC), enteroinvasive E. coli (EIEC), enterotoxigenic E. coli (ETEC), 
enteroaggregative E. coli (EAEC) and diffusely adherent E. coli (DAEC).  While other 
strains are uropathogenic E. coli (UPEC) or cause neonatal meningitis (NMEC) (Croxan 
and Finlay, 2010; Baker K. S., 2015) 
  
1.4 Genetic structure of E.  coli 
E. coli is a diverse species, and commensal and pathogenic strains differ in their genetic 
background and content.  The average number of genes in an E. coli strain is ~4700. Over 
18,000 different orthologous genes have been detected in the species, but only ~2,000 
genes are common to all strains (core genes) of E. coli (Touchon et al., 2009).  The 
mutation rate of E. coli (~1 mutations/year/genome) is much lower compared to species 
like Klebsiella pneumoniae (~10 mutations/year/genome), or Staphylococcus aureus (~8 
mutations/year/genome) (Didelot et al., 2016). 
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1.5 Phylogroups of E.  coli 
E. coli are classified into phylogroups based on their genomic content.  There are four 
main phylogroups, designated A, B1, B2, and D, and four relatively rare phylogroups: C, 
E, F and Clade I (Tenaillon et al., 2010).  Strains belonging to the different phylogroups 
vary in the size of their genomes, propensity to cause disease, ecological niche, and life-
history traits (Archer et al., 2011).  B2, F and D strains are more likely to cause extra-
intestinal infections and A, B1, C or E strains, but most diarrheal causing E. coli are 
derived from phylogroups A, B1, and E. 
 
1.6 Typing of E. coli 
Numerous phenotypic and DNA-based typing methods have been developed for E. coli.    
Although, phenotypic methods cannot be used to determine phylogenetic relationships, 
some of the DNA-based methods can be used infer the phylogenetic relationships 
among different strains (Gordon D. M., 2010). 
  
1.6.1 Phenotypic methods 
Typical phenotypic methods like serotyping, antibiotic resistance and biochemical 
profiling have the potential to discriminate the E. coli strains.  Serotyping of E. coli is 
determined by somatic (O), capsular (K) and flagellar (H) antigens.  Particular O antigens 
are associated with pathogenic strains, therefore O typing E. coli enabled these strains 
to be identified (Orskov, F. and Orskov I., 1992).  Strains of the same serotype do not 
always share a common ancestor.  For instance, Mora et al. (2009) found that isolates 
with an O1: H7 serotype are from two different phylogroups, where 85% were from 
phylogroup D and 15% were from B2.  However, O-typing is expensive, complex, and 
time consuming.  Therefore, allele-specific PCR methods were developed by Clermont 
et al. (2007) enabling isolates to be cost effectively screened for the most clinically 
significant O-types.  WGS-based in-silico serotyping is now the more common method 
to determine serotypes, as the method is reproducible and has a better power of 
discrimination (Joenson et al., 2015). 
 
E. coli is the phenotypically diverse bacterial species, and while collectively the species 
can exploit many different substrates as carbon and nitrogen sources, there is 
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substantial among strain variation.  For example, biochemical profiling of 692 E. 
coli isolates from humans, mammals and the environment revealed 322 distinct profiles 
for 31 biochemical reactions (Walk et al., 2009).  Antibiotics have been used widely to 
treat diseases in recent decades and this has given rise to many antimicrobial resistant 
species, including E. coli.  To identify these resistant E. coli strains, antimicrobial 
resistance profiling can be helpful to find the level of resistance of a particular strain.  
For example, human (n=118) and Australian vertebrate (n=229) isolates yielded 25 and 
13 resistant profiles for 15 antibiotics respectively (Gordon D. M., 2010). 
  
1.6.2 DNA-based methods 
Currently, many DNA-based methods are in use: randomly amplified polymorphic DNA 
(RAPD), repetitive extra-genic palindromic PCR (REP-PCR), multi-locus sequence typing 
(MLST), pulsed-field gel electrophoresis (PFGE), single nucleotide polymorphism (SNP) 
genotyping, and others. 
 
RAPD primers are a random sequence of, usually, ten nucleotides and RAPD assays are 
a cost effect for discriminating E. coli isolates, with the degree of discrimination 
achieved, generally increasing with the number of primers used.  Rep-PCR (primers 
containing repetitive sequence) is a method that can also achieve a high degree of 
discrimination.  However, comparison among different REP-PCR primers suggests that 
not all REP primers achieve the same levels of discrimination.  Mohapatra and 
Mazumder (2008) found that primers such as the enterobacterial repetitive intergenic 
consensus primer (ERIC) has less discrimination ability than (GTG)5 primer.  Although 
best for among strain differentiation, REP-PCR results also yield some information 
concerning the phylogenetic relationships of the strains being compared. 
 
MLST was for many years considered the gold standard for typing bacteria (Maiden et 
al., 1998).  The method is based on Sanger sequencing a 400-500 portion of 7 to 8 
housekeeping genes.  Each distinct sequence for a gene is defined as a different allele, 
and the particular combination of alleles found for an isolate defines its sequence type 
(ST).  An extension of MLST is multi-locus sequence analysis (MLSA), where by the 
nucleotide sequence data for each gene is concatenated and used to infer a phylogenic 
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tree (Larsen et al., 2012).  There are currently three MLST schemes in use for E. coli: 
First, EcMLST database for pathogenic E. coli MLST available at 
http://www.shigatox.net/ecmlst/cgi-bin/index (Qi et al., 2004).  EcMLST database was 
initially created to the characterize Shiga-toxin producing E. coli.  Second, a 7 gene 
scheme was developed by Wirth et al. (2006) and is available at 
http://mlst.warwick.ac.uk/mlst/dbs/Ecoli and the recently developed 8 gene scheme is 
described by Jaureguy et al. (2008) which is available at 
http://bigsdb.pasteur.fr/perl/bigsdb/bigsdb.pl?db=pubmlst_ecoli_seqdef_public.  By 
far the largest database is the Warwick Enterobase scheme, which currently has MLST 
data for over 50,000 isolates (http://mlst.warwick.ac.uk/mlst/dbs/Ecoli).   
 
Pulse field gel electrophoresis (PFGE), is a method whereby DNA is isolated from a 
culture and cut with a restriction enzyme.  The resulting fragments are resolved on an 
agarose gel where the voltage is switched among three directions, thereby allowing 
better resolution of large fragments.  PFGE has more discrimination power than the 
MLST and is easier to interpret than typing PCR-based typing methods.  However, PFGE 
is labor intensive and expensive, and the method is falling into disuse.   
 
SNP genotyping is an excellent method for typing bacterial strains. For example, 13 SNPs 
from the 5 genes (trpA, trpB, putP, icdA, and polB) of E. coli (n=30) strains were selected 
as a reference for grouping and subgrouping of E. coli (n=65) strains (Hommais et al., 
2005).  The SNP data was used to construct a phylogenetic tree (parsimony) that 
demonstrated that SNP genotyping could be suitable for phylogenetic analysis because 
the outcome was concordant with MLST typing (Hommais et al., 2005).  This approach 
was successfully used by Zhang et al. (2006), who illustrated the evolutionary 
relationship between Shiga toxin-producing Escherichia coli (STEC) that are responsible 
for bloody diarrhea and hemolytic uremic syndrome.   
 
The advent of high throughput sequencing methods and rapidly declining library 
preparation and sequencing costs has meant that whole genome sequencing (WGS) is 
replacing many previous typing methods.  There are numerous web-based tools and 
software available to analyze WGS data (Clermont et al., 2015).  For example, the Center 
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for Genomic Epidemiology (CGE) developed a web-based service which is publically 
available at http://www.genomicepidemiology.org/.  CGE platform provides tools for 
detecting virulence and antimicrobial resistance genes, sequence type determination, 
serotyping, and phylogenetic analysis. 
 
 
1.7 Factors influencing E. coli diversity: Among host variation 
The probability of detecting E. coli in a mammal varies with the host body size and 
diet.  E. coli is rare in insectivorous bats; and among the carnivorous marsupials, the 
probability of detecting E. coli increases with host body mass.  Among non-human 
vertebrates, B1 strains are most prevalent in fish, reptiles, birds and mammalian 
carnivores, while B2 strains are most prevalent in hosts with a hindgut fermentation 
chamber (Gordon & Cowling., 2003).  Phylogroup D strains are more likely to be isolated 
from birds and mammals than from other vertebrates.  Among humans, B2 strains are 
most likely to be observed in people residing in developed countries in the temperate 
regions of the world, while A and B1 strain predominate in people residing in tropical 
regions and developing countries (Escobar – Páramo et al., 2004; Skurnik et al., 2008).  
The rate at which the material moves through the gut varies with host diet and body 
mass.  Transit times tend to increase with host body mass.  While animals having a 
largely plant-based diet tend to have slower gut transit times, largely due morphological 
changes associated with a plant-based diet: the need for a fore or hind-gut fermentation 
chamber.  The results of the survey studies indicate that the interactions among hosts 
diet, gut morphology and dynamics are important determinants of the genetic structure 
of E. coli populations in different host species.  Experimental studies support the notion 
that diet and gut dynamics influences the diversity of E. coli present in the host. 
 
O’Brien and Gordon (2011) showed that in rats fed on diets varying in their amount of 
non-fermentable fibre E. coli cell densities varied with the turnover rate of the gut.  In 
addition, in animals on high fibre diets, animals where B2 strains dominated had lower 
cell densities than when an animal’s E. coli population was dominated by a B1 strain 
(O’Brien and Gordon, 2011).  In another experiment, it was found that as the difference 
between liquid and particle retention times increased, E. coli faecal cell densities 
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decreased, while the likelihood that an animal’s dominant E. coli strain possessed a gene 
involved in adhesion (agn43) increased (Blyton et al. 2015). 
  
1.8 Factors influencing E. coli diversity in humans: within host variation 
Studies examining human faecal isolates of E. coli typically detect 1-3 genotypes per 
host although as many as 9 or more genotypes have been detected (Alm et al., 2011).  
Studies of pigs and humans indicate that E. coli strain diversity based on faecal isolates 
may underestimate the actual number of strains present in the host.  The data suggest 
that there are strains present in the small intestine that are not detected in faeces.  
There is also data from E. coli isolated from pigs that indicates the genotypic 
characteristics of strains isolated from different regions of the gut may also vary (Dixit 
et al., 2004; Abraham et al., 2012).  Although tissue tropism is well-recognized 
phenomena among diarrheal E. coli (Fitzhenry et al., 2002), with some diarrheal types 
targeting cells are in the terminal ileum and others colon cells (Donnenberg, M., 2013).  
O157:H7 is a diarrheal pathogen of humans, but a commensal of cattle. In cattle, 
O157:H7 is more likely to be detected in the rectum than in other regions of the gut or 
in the faeces (Croxan and Finlay, 2010).  It is not clear how common tissue tropism is 
among non-diarrheal strains of E. coli.  In a study that isolated E. coli from biopsies taken 
from 5 regions of the human gut (terminal ileum, ascending, transverse and descending 
colon, and rectum) there was no indication that strain diversity changed with the biopsy 
location (Gordon et al., 2015).  However, there were strains detected in either the 
terminal ileum or rectum that were not detected in any other gut region, suggesting that 
tissue tropism might exist for strains inhabiting the human gut (Gordon et al., 2015). 
 
Some studies have also indicated that human host age or sex plays a role in determining 
the diversity and genetic structure of E. coli in a person.  The phylogenetic membership 
of the dominant strain has been shown to change with host age (Gordon et al., 2005; 
Vollmerhausen et al., 2011), while the number of strains detected per host has been 
shown to increase with host age (Vollmerhausen et al., 2011).  These observations 
accord with the non-human mammal survey studies and experimental studies with 
regard to the importance of gut dynamics.  In human females, small intestine and colon 
transit times are 50% slower than males.  Moreover, transit times change as humans 
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age, with small intestine transit times decreasing and large intestine transit times 
increasing with age (Graff et al., 2000).  However, not all studies have been able to 
demonstrate the effect of host age on the composition of human E. 
coli populations (Escobar-Páramo et al., 2004; Li et al., 2010). 
 
Within-host competition also appears to play a role in determining the diversity of 
strains found in a host.  Several studies have observed that when a B2 strain is 
numerically dominant fewer strains will be detected in the host than in hosts where a 
strain belonging to phylogroups A, B1 or D is numerically dominant (Moreno et al., 
2009).  That is, the presence of a B2 strain in a host appears to inhibit the establishment 
of other strains.  
 
Humans are exposed to E. coli on a daily basis, with estimates suggesting humans ingest 
106 cells of E. coli with every gram of food eaten (Hartl & Dykhuizen, 1984).  However, 
as the survey and experimental studies show, the strains which succeed in establishing 
in a host are a non-random subset of the strains to which a host is exposed.  Although 
the precise factors determining the type of strain establishing in a host are unknown. 
 
Studies examining multiple isolates from a single host provide additional evidence 
supporting the conclusion that only particular strains will succeed in getting established 
inside a host.  Several studies have shown that when two or more strains are present in 
a host, the second most abundant strain is significantly more likely to belong to the same 
phylogroup as the numerically dominant strain (Smati et al., 2014; Blyton et al., 2014; 
Gordon et al., 2015).  
 
There are non-mutually exclusive explanations for the observation that when two or 
more strains are found in a host they are more likely to be members of the same 
phylogroup, rather than different phylogroups.  One explanation is that unknown 
factors related to the gastrointestinal environment, determine the kind of strains that 
can be established inside a host.  That is, if a host exhibits a gut environment conducive 
to the establishment of, for example, a B2 strain rather than strains of the other 
phylogroups, then when a host harbours more than one strain they will be members of 
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the same phylogroup.  The other explanation is that the presence of two or more strains 
belonging to the same phylogroup in a host is a result of within-host evolution events.  
That is, a strain of a particular phylogroup succeeds in getting established inside a host 
and persists long enough for variants of the original strain to appear.  Although there is 
relatively little data, there are examples of E. coli strains persisting in a host for from 2-
5 years (Clermont et al., 2008).  Long-term E. coli evolution studies in mice, have shown 
that new variants will arise and be detected in strains persisting in a host for a year 
(Lee et al., 2010). 
  
1.9 Aim of the study 
The aim of this study is to determine, in hosts harbouring multiple strains belonging to 
the same phylogroup, what fraction represent independent immigration and 
establishment events versus what fraction represent diversity arising as a consequence 
of within-host evolution. 
 
To investigate this question, I will exploit a large collection of strains isolated from 
biopsies taken from different gut regions of 67 patients undergoing the colonoscopy and 
characterized using REP-PCR fingerprinting (Gordon et al., 2015).  One example of every 
fingerprint type available from a patient was whole genome sequenced and these data 
were used to address the aims of the study. 
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2.1 Strain Collection 
This study was based on a collection of strains reported by Gordon et al.  (2015).   In this 
study, biopsies were collected from 69 patients undergoing colonoscopies at the 
Canberra Hospital, Canberra, Australia in 2010 and 2011.  Biopsies were collected from 
up to five gut regions in each patient: terminal ileum, ascending colon, transverse colon, 
descending colon and rectum.  All the details of disease condition of each patient are 
presented in appendix 1.  Up to 20 isolates of E. coli were recovered from each biopsy.  
All isolates were REP-PCR fingerprinted using two primers (CCG)5 and ERIC (Adamus-
Bialek et al., 2009) and assigned to a phylogroup using the Quadruplex method 
(Clermont et al., 2013). 
 
2.2 Whole genome sequencing 
Some isolates from this study were previously sequenced as a part of study of adherent 
invasive E.  coli (O’Brien et al., 2016) using the Illumina HiSeq 2000 platform.  In addition 
to these isolates, an attempt was made to whole genome sequence one example of each 
fingerprint type detected in every host.  However, -80°C cultures were not available for 
every fingerprint type from each patient, as some had been lost while the Gordon et al. 
(2015) study was being carried out. 
 
DNA from every available isolate was extracted from a 100 µL aliquot of an overnight 
lysogeny broth culture using the ISOLATE II Genomic DNA Kit – For Bacteria (Bioline) 
according to manufacturer’s protocol.  Qubit® dsDNA BR quantification was used to 
determine the concentration of DNA using a Qubit® Fluorometer (Invitrogen™).  After 
quantification DNA samples were diluted to achieve a final concentration of 0.2 ng/µL.  
DNA libraries were made using the Nextera® XT DNA library preparation kit (Illumina®) 
and the Nextera XT Index Kit (Illumina®) according to the manufacturer’s protocols.  
Libraries were sequenced using the MiSeq® system (Illumina®) together with the MiSeq 
Reagent Kit v3 (600-cycles).  Forty eighty strain were sequenced per MiSeq run. 
 
2.3 Microbial genome assembly 
The A5MiSeq (Andrew And Aaron’s Awesome Assembly pipeline)-MiSeq assembly 
software was used to assemble the read data for each isolate (Coil et al., 2015).  The 
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WGS data for every strain was submitted to Enterobase 
(http://enterobase.warwick.ac.uk/) and is publically available. 
 
2.4 Basic characterization 
The strains were assigned to sequence types (STs) using the University of Warwick MLST 
scheme (http://enterobase.warwick.ac.uk/).  The Centre for Genomic Epidemiology 
(CGE) website (http://www.genomicepidemiology.org/) tool SeroTypeFinder (Joensen 
et al., 2015) was used to determine the serotype of all isolates.    
 
2.5 CSIPhylogeny - Variant finding 
In this study, comparisons between related strains were done using the CSIPhylogeny 
tool (Kaas et al., 2014).  Variant calling or Single Nucleotide Polymorphism (SNP) calling 
is the simplest method to find the difference between strains.  This tool is publically 
available at http://cge.cbs.dtu.dk/services/CSIPhylogeny/.   
 
2.6 Annotation of variants 
A tool from Pathosystems Resource Integrated Center (PATRIC) was used to identify and 
annotate the variants.  The PATRIC analysis tool is available on 
http://www.beta.patricbrc.org/app/variation.  This tool maps read data against a 
reference genome and provides a detailed description of the variants detected.  The first 
stage in variant detection is annotation of the reference genome.  PATRIC uses Rapid 
Annotations using Subsystems Technology (RAST) for genome annotation (Wattam et 
al., 2014).  The differences between each combination of strains observed in this study 
that were inferred to represent within host evolution events were investigated.  For 
each pair of strains compared, one strain was used as the reference strain and the raw 
read data from the other strains mapped to the reference, the process was then 
repeated by switching the role of each strain.  
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3.1 Host characteristics 
Biopsies were collected from 67 patients out of which 32 were female and 35 male.  
Individuals ranged from 18 to 73 years of age.  The disease state of each individual was 
determined based on an individual’s clinical history and the appearance of the gastro-
intestinal tract during the colonoscopy: 32 individuals were diagnosed with Crohn’s 
disease, 17 with ulcerative colitis, and 18 of the individuals had gastro-intestinal tracts 
that appeared to be disease free.  Age, sex and disease state for each individual is 
presented in Appendix 1. 
 
3.2 SNP detection 
Strains belonging to different phylogroups or sequence types (STs) isolated from the 
same host were considered to be a consequence of independent exposure and 
establishment events.  However, a number of individuals harboured isolates belonging 
to the same ST, but which were found to represent different REP types based on 
previous REP-PCR fingerprinting (Gordon et al., 2015). 
 
In order to determine if isolates from the same individual and belonging to the same ST 
could be considered distinct strains, it was necessary to first determine how many SNPs 
could be observed between the assemblies of the same isolate that had been whole 
genome sequenced on two separate occasions.  If the number of SNPs observed 
between two isolates exceeded the number of SNPs observed between the same isolate 
sequenced twice then the two isolates were defined as representing different strains, if 
not, then the two isolates were considered to be multiple examples of the same strain. 
 
In order to determine the number of SNPs differentiating two isolates, the SNP detection 
method Call SNPs and Infer Phylogeny (CSIPhylogeny) (Kaas et al., 2014) implemented 
at the Centre for Genomic Epidemiology web site 
http://cge.cbs.dtu.dk/services/CSIPhylogeny was used.  CSIPhylogeny maps the raw 
sequence data for an isolate against a reference strain.  The method implements a 
number of quality control steps.  The minimum amount of coverage at a SNP position 
can be varied.  Base call quality and read quality can also be varied.  Base quality is a 
measure of the accuracy with which a base has been called, while read quality is a 
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measure of the accuracy with which a single read has been mapped to the reference.  In 
CSIPhylogeny two other quality control steps have been implemented.  One is the 
minimum relative depth at a SNP position, this step represents an attempt to control 
situations where the level of coverage varies extensively for the WGS data for different 
samples (e.g. 20x vs 1000x coverage).  As the great majority of the WGS data in the 
present study had broadly similar levels of coverage this option was disabled in 
CSIPhylogeny.  In CSIPhylogeny, there is also the ability to control the minimum distance 
allowed between SNPs, but this option was disabled as the goal was to detect all SNPs. 
 
 
Figure 3.1.  Number of SNPs detected using the detection method CSIPhylogeny (Kaas et al., 2014) as a 
function of base call and read mapping quality, and coverage. 
 
In order to select the appropriate cut-offs for the various quality control parameters the 
WGS data for the ST73 strain 23-1-TC4 was used together with the assembly for the ST73 
reference strain CFT073.  First all quality control parameters, except for the one being 
investigated were disabled.  Then a value was chosen for the remaining quality control 
parameter (e.g.  depth at SNP position) and the number of SNPs detected was recorded.  
This procedure was repeated using different values for the quality control parameter.  
The same procedure was used to investigate the impact of the other quality control 
parameters on the number of SNPs detected. 
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Coverage at a SNP was found to be the most important parameter in determining the 
number of SNPs detected.  When coverage at a SNP position was disabled significantly 
more SNPs were detected regardless of the score used for base call quality or read 
mapping quality (Fig. 3.1).  For example, a quality score of 20 (99% probability of being 
correct) for read mapping quality yielded 76 SNPs while 70 SNPs were detected when a 
quality score of 20 was used for base calling accuracy.  By contrast, when a coverage 
value of 20 was used only 4 SNPs were detected.  As a consequence, it was decided that 
all SNP detections would be determined using a read mapping quality score of 25, a SNP 
quality score of 30, a SNP depth score of 10, and all other options were disabled. 
 
3.3 Defining isolates as distinct 
The first step in determining if two isolates belonging to the same ST were distinct was 
to determine the number of SNPs detected when comparing the WGS data for the same 
strain that had been independently sequenced twice. Two independent culture of the 
same strain of 19 samples were used for DNA extraction and for WGS. However, two 
sets of WGS data was available for a total of 19 strains (Appendix C).  To determine the 
number of SNP differences between the two sets of WGS data the following approach 
was used.  CSIPhylogeny was used to detect SNPs using the parameter setting described 
previously.  Each set of read data was assembled using the A5MiSeq pipeline and the 
raw read data from one sequence run was mapped against the assembly for the other 
sequence run of the strain and the number of and position of all SNPs determined.  The 
procedure was then repeated using the other set of sequence data as the assembled 
reference and the raw read data.  The predictions of the two analyses were compared 
and the true SNPs were considered to be those SNPs detected in both sets of SNP data. 
 
The result of this analysis revealed that in 17 of the 19 cases of the same isolate being 
sequenced twice there were no SNP differences detected between the two assemblies.  
In two cases (10.5%) a single SNP difference was detected.  Therefore, if the WGS data 
of two isolates representing the same ST differed by less than two SNPs then these two 
isolates were considered to represent two examples of the same strain.  If two or more 
SNPs were detected, then these two isolates were considered to represent different 
strains. 
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3.4 Strain diversity within hosts 
WGS data was available for 174 isolates from 67 hosts.  Based on REP-PCR fingerprinting 
these were predicted to represent 158 distinct genotypes (on average, 2.3 genotypes 
per individual).  The balance of the 174 isolates represented 16 cases where isolates 
with the same REP-PCR fingerprint type, but from different gut regions of the same 
patient were sequenced. 
 
The ST of all isolates was determined.  Isolates representing the same ST from the same 
patient were compared in a pairwise fashion in order to determine if the isolates did 
represent distinct strains, that is, the pair of isolates being compared differed by 2 or 
more SNPs.  There was a total of 113 isolates representing the same ST from the same 
patient and 34 of these actually represented distinct strains.  Therefore, while strains 
belonging to different STs always had different REP-PCR fingerprints, there were cases 
where isolates belonging to the same ST from the same host but with different REP-PCR 
fingerprints did not in fact represent different strains. 
 
The diversity of strains within each of the 67 hosts is presented in Table 3.1.  In several 
cases WGS data was not available for an isolate as no culture existed.  However, the 
phylogroup membership of the missing isolate was known as was its virulence factor 
profile.  There were two cases (Hosts 6 and 8) where the virulence factor profile clearly 
indicated that there were two very different strains of the same phylogroup although 
WGS data was not available for one of the strains.  Overall, there was an average of 2.1 
strains per host. 
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Table 3.1.   Phylogroup and sequence type (ST) of the distinct strains detected in each patient.  A migration 
event denotes a case when the patient harbours two or more strains representing different STs or 
belonging to the same ST but differing by more than 1000 SNPs.  A within- host evolution event denotes 
two or more strains of the same ST than differ by more than 2 but less than 50 SNPs.  (See text for further 
details) 
Host 
Genotype Number 
Migration 
Events 
Within-Host 
Evolution 
Events 
1 2 3 4 5 
1 B2 (91) D (349)    2 0 
3 B2     1 0 
4 D (69)     1 0 
5 B2 (95)     1 0 
6 B2 (95) B2    2 0 
7 D (349) B2    2 0 
8 A (10) B1 (270) D (3300) D  4 0 
9 A B2 (131)    2 0 
10 B2 (131)     1 0 
11 D (69)     1 0 
12 B2 (127) B2 (127)    1 1 
13 B2 (420) B2 (420)    1 1 
14 B2 D (3056    2 0 
15 A B2 (91)    2 0 
16 A (216) A (216) B2   2 1 
17 B1 F (59) F (59)   2 1 
18 B1 (906) B2 (73)    2 0 
19 B2 (14) B2 (14) B2 (14) B2 (14)  1 3 
20 B1 (1304) B1 (1304) B2 (73)   2 1 
21 B2 (73) B2 (73)    1 2 
22 D (69)     1 0 
23 B2 (73) B2 (73) B2 (73)   2 1 
24 A B1 (58) B2 (28)   3 0 
25 D (132) D (362)    2 0 
26 D (973) F (1674)    2 0 
27 B2 (95)     1 0 
28 D     1 0 
29 B1 (1049) B2 (589) D (362) D (362)  3 1 
30 F (648)     1 0 
32 B2 (131) B2 (420)    2 0 
33 B1 (1727) B2 (131)    2 0 
35 B2 (95)     1 0 
36 B2 (429) B2 (429)    1 1 
37 B1 (6171)     1 0 
39 B2 (95) B2 (95)    1 1 
40 B2 (95) B2 (95)    1 1 
41 D (720)     1 0 
42 A (48)     1 0 
43 B1 (1642) B1 (2773)    2 0 
44 B1 (58) B1 (58)    1 1 
45 A (398) B2 (95) B2 (144)   3 0 
46 B2 (95) D (69)    2 0 
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Host 
Genotype Number Migration 
Events 
Within-Host 
Evolution 
Events 1 2 3 4 5 
47 B1 (160) B2 D (110) D (1567)  4 0 
48 B2 (12) B2 (12)    1 0 
50 A (6174) B1 (154) B1 (6169)   3 0 
51 B1 (1727) D (108)    2 0 
52 B2 (95) B2 (550)    2 0 
53 B1 (58) B1 (58)    1 1 
54 B2 (1919) B2 (1919)    1 1 
55 B2 (131) B2 (131)    1 1 
56 B2 (95) D (6170) D (6170) D (6170)  2 2 
57 A (409) B2 (537)    2 0 
58 A (607) B2 (28)    2 0 
59 A (653)     1 0 
60 B2 (80) D    2 0 
61 B2 (95)     1 0 
62 B1 (223) B2 (12) B2 (95)   3 0 
63 B2 (80) D (963)    2 0 
65 A (10) D (1177) D (1177)   2 1 
66 B2 D (938)    2 0 
67 A (216) D (132) D (362)   3 0 
68 B1 (517) D (362)    2 0 
69 B2 (569)     1 0 
70 B2 (95) B2 (569) D (69) D (362)  4 0 
71 D (362) F (1674)    2 0 
72 B1 B2 (131) B2 (569) D (132) D (362) 5 0 
73 B1 (2005)     1 0 
 
3.5 Immigration/Establishment versus within-host evolution 
The presence of a one strain in a host represents an immigration/establishment event.   
In hosts with two or more strains, every strain present in a host that belonged to a 
different ST was also assumed to represent a different immigration/establishment 
event.  When a host harboured two or more strains belonging to the same ST these 
strains could either represent independent immigration/establishment events or be the 
result of within-host evolution. 
 
To distinguish between these two possibilities the average number of SNPs observed 
between strains belonging to the same ST isolated from different hosts was first 
assessed.  Data was available for strains belonging to 16 STs (Table 3.2).  On average, 
two strains belonging to the same ST but isolated from different hosts, differed by 4135 
SNPs although this value varied considerably among STs. 
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Table 3.2.  The average number of SNPs detected among strains belonging to the same sequence type 
(ST) but isolated from different patients. 
Sequence Type Mean Number of SNPs Number of strains 
80 4370 2 
349 3300 2 
1727 9845 2 
10 6676 2 
12 61 2 
91 1735 2 
420 1458 2 
132 849 3 
569 2 3 
58 4567 5 
216 2448 3 
362 3516 8 
131 8730 7 
73 4358 7 
69 10771 5 
95 3489 15 
 
By contrast, strains belonging to the same ST from the same host differed by fewer than 
12 SNPs (Figure 3.2).  There was one exception, Host 23, harboured three ST73 strains.  
One of these strains differed from the other ST73 strains by an average of 6332 SNPs, 
while the other ST73 strains in the host differed by two SNPs.  Thus, two quite different 
ST73 strains succeeded in establishing in this host and one has given rise to another 
variant as a result of within-host evolution. 
 
 
Figure 3.2: Distribution of the number of SNP differences between strains isolate from the same host 
and belonging to the same ST. 
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The criteria used to distinguish between immigration/establishment events and within 
host evolution is also illustrated by depicting the phylogenetic relationships among all 
ST58, ST69, ST73, ST95, ST131 and ST 362 strains observed in this study (Fig. 3.3).  The 
phylogenetic tree was constructed using MEGA to find the relatedness of major STs of 
this study. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3.  Phylogenetic relationships among the sequence types 58, 69, 73, 65, 131 and 362 strains 
observed in this study.  The first number in the strain name denotes the patient from which the isolates 
were taken.  This phylogenetic tree is based on the strains of the same STs from same patients which is 
representing different immigration/establishment events within-host. 
ST69 
 
ST362 
 
ST58 
 
ST131 
 
ST73 
 
ST95 
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When a host harboured two or more strains belonging to the same phylogroup it could 
be due to immigration/establishment or within-host evolution.  There were 33 cases of 
two of more strains belonging to the same phylogroup in a single host (Table 3.1).  
Within-host evolution accounted for the presence of another strain of the same 
phylogroup in 54 % of the cases, while in 45% of the cases this outcome was due to 
independent immigration/establishment events (Table 3.1). 
 
The relative importance of within-host variation versus immigration/establishment in 
explaining the presence of two or more strains of the same phylogroup did not vary 
among phylogroups (Likelihood Ratio X2 = 3.6, p = 0.46) (Table 3.3). 
 
Table 3.3.  Fraction of cases where the presence of two or more strains within a host was a consequence 
of within-host evolution versus migration/establishment as a function of the phylogroup membership of 
the strain. 
Phylogroup N Within Host Evolution Migration 
A and F 2 100 % 0 % 
B1 5 60 % 40 % 
B2 18 61 % 39 % 
D 8 37 % 63 % 
 
3.6 Genetic changes and within-host evolution 
Within-host evolution events accounted for a substantial portion of the within host 
strains diversity observed in this study.  The nature of the changes that occurred in the 
strains that evolved within the host was investigated using the variant detection tool 
available at the PATRIC website (https://www.patricbrc.org/app/Variation). 
 
Comparison of the strains inferred to have evolved within a host revealed that, on an 
average, 13% of the changes were in non-coding regions, 21% represented synonymous 
changes, and 66% non-synonymous changes (Table 3.4).  However, the observed 
mutations occurred in genes with a variety of functions and there appeared to be little 
pattern in the functional nature of the genes in which mutations were observed (Table 
3.4). 
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Table 3.4.   Mutations occurring in strains inferred to have been derived as a result of within-host evolution. 
Patient Phylogroup ST Strains compared Strain 1 Strain 2 Mutation Function 
12 B2 127 12-1-Ti12/12-2-Ti13 T G Synon Oligopeptide transport permease protein 
T C Noncod  
T C Synon MFS superfamily export protein YceL 
13 B2 420 13-3-TC6/13-2-TC5 A T Nonsyn Tyrosine-protein kinase Wzc (EC 2.7.10.2) 
A G Noncod  
16 A 216 16-3-C13/16-2-Si18 T C Noncod  
G A Nonsyn Aminobenzoyl-glutamate transport protein 
17 F 59 17-1-R20/17-2-DC14 T C Nonsyn Lipoprotein NlpI 
T G Nonsyn LsrR, transcriptional repressor of lsr operon 
19 B2 14 19-1-TC4/19-1-Ti7 A G Nonsyn PTS system, mannitol-specific cryptic IIB component (EC 2.7.1.69) 
G A Nonsyn FIG00638808: hypothetical protein 
G A Synon Co-activator of prophage gene expression IbrB 
19-2-Ti6/19-2-TC6 T G Nonsyn Uncharacterized substrate-binding protein YbaE 
T G Nonsyn Probable diguanylate cyclase YeaP 
A C Noncod  
A G Nonsyn FIG00638808: hypothetical protein 
19-1-Ti7/19-2-TC6 T G Nonsyn Uncharacterized substrate-binding protein YbaE 
A G Nonsyn FIG00638808: hypothetical protein 
 
19-3-TC2/19-1-Ti7 
A G Synon Co-activator of prophage gene expression IbrB 
G T Nonsyn Uncharacterized substrate-binding protein YbaE 
G A Synon Co-activator of prophage gene expression IbrB 
19-2-TC6/ 19-1-TC4 A G Nonsyn PTS system, mannitol-specific cryptic IIB component (EC 2.7.1.69) 
20 B1 1304 20-2-TC3/20-3-TC12 G A Nonsyn Outer membrane lipoprotein pcp precursor 
T C Nonsyn Error-prone, lesion bypass DNA polymerase V (UmuC) 
20-1-TC6/20-2-TC3 A G Nonsyn Outer membrane lipoprotein pcp precursor 
C T Nonsyn Error-prone, lesion bypass DNA polymerase V (UmuC) 
T C Nonsyn Putative anti-FlhC (2) FlhD (4) factor YdiV 
20-1-TC6/20-3-TC12 T C Nonsyn Putative anti-FlhC (2) FlhD (4) factor YdiV 
21 B2 73 21-1-TC7/21-2-C8 A C Nonsyn Enterobactin synthetase component F, serine activating enzyme (EC 2.7.7.-) 
A G Nonsyn Allantoinase (EC 3.5.2.5) 
T G Nonsyn 4-hydroxy-3-methylbut-2-enyl diphosphate reductase (EC 1.17.1.2) 
T C Synon Intramembrane protease RasP/YluC 
C T Nonsyn Helicase PriA essential for oriC/DnaA-independent DNA replication 
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Patient Phylogroup ST Strains compared Strain 1 Strain 2 Mutation Function 
23 B2 73 23-1-TC4/23-2-Ti8 C A Nonsyn Phosphoenolpyruvate-protein phosphotransferase of PTS system (EC 2.7.3.9) 
A G Noncod  
23-1-TC4/23-3-Ti9 C A Nonsyn Phosphoenolpyruvate-protein phosphotransferase of PTS system (EC 2.7.3.9) 
T C Noncod  
23-1-TC4/23-2-AC12 C A Nonsyn Phosphoenolpyruvate-protein phosphotransferase of PTS system (EC 2.7.3.9) 
23-2-AC12/23-2-Ti8 A G Noncod  
29 D 362 29-1-DC3/29-4-DC8 T C Nonsyn Endonuclease IV (EC 3.1.21.2) 
G A Nonsyn DNA sulfur modification protein DndB 
T G Nonsyn FIG00642784: hypothetical protein 
36 B2 429 36-1-TC9/36-1-Ti13 C T Synon Peptidyl-prolyl cis-trans isomerase PpiD (EC 5.2.1.8) 
T C Nonsyn Hypothetical protein 
C T Noncod  
T C Synon Thiol: disulfide interchange protein DsbG precursor 
G A Nonsyn Quinolinate phosphoribosyltransferase [decarboxylating] (EC 2.4.2.19) 
C T Noncod  
C T Synon LysR family transcriptional regulator YafC 
C T Synon Succinate dehydrogenase flavoprotein subunit (EC 1.3.5.1) 
39 B2 95 39-2-Ti8/39-1-AC10 G A Nonsyn Putative HTH-type transcriptional regulator ybaO 
G C Nonsyn Fumarate respiration sensor kinase protein DcuS 
40 B2 95 40-3-R7/40-1-R9 A C Nonsyn Putative HTH-type transcriptional regulator ybaO 
T C Nonsyn Putative HTH-type transcriptional regulator ybaO 
C T Nonsyn Formate hydrogenlyase subunit 3 
44 B1 58 44-4-Ti15/44-1-Ti4 A C Nonsyn HMP-PP hydrolase (pyridoxal phosphatase) Cof 
G A Synon Mobile element protein 
53 B1 58 53-1-AC6/53-1-AUC1 C G Nonsyn Membrane-bound lytic murein transglycosylase F (EC 4.2.2.n1) 
G A Synon Ribulokinase (EC 2.7.1.16) 
54 B2 1919 54-1-TC4/54-1-Ti6 A G Nonsyn Hybrid sensory histidine kinase 
G T Noncod  
G T Nonsyn Exoribonuclease II (EC 3.1.13.1) 
55 B2 131 55-1-TC9/55-1-Ti19 C A Nonsyn Glutaminase (EC 3.5.1.2) 
C T Nonsyn Tas protein, an NADP(H)-dependent aldo-keto reductase 
G T Synon ATP-dependent helicase HrpA 
G A Nonsyn Probable diguanylate cyclase YedQ 
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 Patient Phylogroup ST Strains compared Strain 1 Strain 2 Mutation Function 
56 D 6170 56-1-AC4/56-3-AC1 A C Nonsyn [Protein-PII] uridylyltransferase (EC 2.7.7.59) 
A T Nonsyn Asparagine synthetase [glutamine-hydrolyzing] (EC 6.3.5.4) 
A G Synon Putative structural protein 
56-1-AC4/56-4-R1 A C Nonsyn [Protein-PII] uridylyltransferase (EC 2.7.7.59) 
G T Synon Lysine/cadaverine antiporter membrane protein CadB 
T C Nonsyn N-acetylglucosamine-6-phosphate deacetylase (EC 3.5.1.25) 
A G Synon Putative structural protein 
56-3-AC1/56-4-R1 G T Synon Lysine/cadaverine antiporter membrane protein CadB 
G A Synon AI-2 transport protein TqsA 
G A Noncod Acetyl-CoA acetyltransferase (EC 2.3.1.9) 
T A Nonsyn Asparagine synthetase [glutamine-hydrolyzing] (EC 6.3.5.4) 
T C Nonsyn N-acetylglucosamine-6-phosphate deacetylase (EC 3.5.1.25) 
65 D 1177 65-1-AC2/65-4-AC20 C A Nonsyn Anaerobic selenate reductase 
T C Nonsyn Protein involved in stability of MscS mechanosensitive channel 
T C Nonsyn FIG00031715: Predicted metal-dependent phosphoesterases (PHP family) 
G A Nonsyn FIG00640233: hypothetical protein 
C A Noncod  
A G Nonsyn Electron transfer flavoprotein, beta subunit FixA 
C G Synon Putative NAGC-like transcriptional regulator 
C A Nonsyn FhuE receptor precursor 
C T Synon Pseudouridine transporter PsuT (putative) 
G C Nonsyn Sodium-Choline Symporter 
T A Nonsyn 62kDa structural protein 
65-1-AC2/65-3-TC1 C T Synon Pseudouridine transporter PsuT (putative) 
A G Nonsyn FIG006303: protein yraQ 
A C Nonsyn DEAD-box ATP-dependent RNA helicase CshA (EC 3.6.4.13) 
T C Nonsyn Lipopolysaccharide-assembly protein LptC 
C A Noncod  
C A Nonsyn FhuE receptor precursor 
T C Nonsyn Putative transport protein YbjL 
A G Nonsyn Oligopeptide transport substrate-binding protein 
C T Nonsyn FIG00638098: hypothetical protein 
C T Nonsyn 3-dehydro-L-gulonate 2-dehydrogenase (EC 1.1.1.130) 
T C Nonsyn Transcriptional regulatory protein PhoP 
G C Nonsyn Sodium-Choline Symporter 
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Escherichia coli resides in the gastrointestinal tract of humans and the diversity, density 
and dominance of these strains depends on the numerous factors, such as, host age, 
sex, and diet, digesta retention times, gut morphology, as well as what strains the host 
is exposed to.  This study asks the question, if a host harbours multiple strains belonging 
to the same phylogroup, then what fraction represent immigration/establishment 
events versus what fraction represent within host evolution events?  In this study 83% 
of the strain richness observed in a host was a consequence of 
immigration/establishment events, rather than within host evolution.  However, when 
only hosts harbouring strains of the same phylogroup are considered, then about half 
(54%) of the observed strain richness is a result of within host evolution events and the 
balance due to immigration/establishment events. 
 
4.1 Caveats 
Before discussing the significance of these results, I will examine the potential 
limitations of the study.  Not all of the fingerprint types detected in every patient were 
available for sequencing.  In order to avoid producing a freezer culture of every one of 
the almost 5000 isolates collected during the original study, it was decided to only make 
freezer cultures of one example of every fingerprint type detected in every gut region 
from each of the patients examined.  Consequently, strains had to be fingerprinted and 
assigned a phylogroup prior to choosing the isolates for which freezer cultures would be 
made. While the isolates were being characterised they were stored on lysogeny broth 
plates at 5°C.  During the time taken to characterise the isolates, some isolates died 
while being stored at 5°C.  Those REP fingerprint types represented by a single isolate 
were more likely to be lost than those represented by multiple isolates.  It also took 
significantly more time to characterise the isolates from the first set of patients 
examined compared to the isolates from subsequent sets of patients, and consequently 
more REP types were lost from this initial set of patients than subsequent sets.  The loss 
of REP-PCR fingerprint types had the result that the number of strains observed per host 
based on whole genome sequencing (Table 3.1) was less than the average number of 
strains per host reported by Gordon et al. (2015). 
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The proportion of isolates for which WGS data was available that belonged to each 
phylogroup was not significantly different from the relative abundance of phylogroups 
reported in Gordon et al. (2015) (Table 4.1).  This suggests that the isolates that were 
lost were likely a random subset of all isolates.  In turn, this would suggest that the 
estimated ratio of immigration/establishment events versus within-host evolution 
events is also unbiased. 
 
Table 4.1. Comparison of relative abundance of phylogroups distribution between 
Gordon et al. (2015) and this study. 
Phylogroup 
Relative abundance of dominant phylogroups 
Gordon et al. (2015) study This study 
A 7.2% 9.7% 
B1 14.5% 16.1% 
B2 44.9% 43.7% 
D 24.6% 27.0% 
E 2.9% 0.0% 
F 5.8% 3.4% 
 
 A very conservative approach was taken in determining the number of SNP differences 
between two strains.  Read mapping quality and base call quality scores were chosen to 
be greater than 20 (>99.9% confidence).  Each potential SNP had to be represented by 
at least 10 reads.  Less stringent requirements would result in greater absolute number 
of SNPS being called, but should not change the observation that the average number 
of SNPs observed between two strains belonging to the same ST and from the same 
patient should be greater than the average number of SNPS detected between the same 
strain sequenced twice and significantly smaller than the average number of SNPs 
detected between isolates of the same ST but from different patients.  For strains 
representing within-host evolution events (belonging to the same ST and from the same 
host), SNP estimates were available using the CSIPhylogeny and variant detection tool 
in PATRIC (https://www.patricbrc.org/public/pdfs/Workshop-Variation-
Service.pdf).  Among the within host evolution comparisons CSIPhylogeny detected an 
average of 10 SNPs while PATRIC called an average of 78 SNPS and the correlation 
between the number of SNPs called by each method was (r=0.89).  
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4.2 The host as a determinant of E. coli clonal diversity 
 There are now numerous studies that have shown that E. coli genotypes are non-
randomly distributed among hosts (Alm et al., 2011; Gordon et al., 2015).  In particular, 
several studies have shown that when a host harbours two or more strains these strains 
are significantly more likely to be members of the same phylogroup.  This study has 
shown that in about half of such cases, this is due to the immigration and establishment 
of strains and not within host evolution.  Thus, the results of this study show that despite 
hosts being regularly exposed to a diversity of E. coli through the food that they eat, 
factors related to the host, at least in part, determines what E. coli strains succeed in 
establishing.  
 
The precise nature of these factors is unknown.  Studies examining the distribution of 
phylogroups in humans sampled in different parts of the world show systematic 
differences (Escobar-Páramo et al., 2004; Duries et al., 2001).  B1 and A strains dominate 
in faecal samples collected from humans living in tropical/developing countries, while 
B2 strains are recovered from about 50% of humans living in temperate/developed 
countries.  There are substantial differences in the diets of people living in developed 
versus developing countries.  In developing countries meat represents a smaller fraction 
of the diet relative to legumes and grains, while the opposite is true of the diets of 
people living in developed countries.  People living in developed countries also have 
diets that are often based on highly processed foods.  A recent study showed that over 
the past 30 years’ people in the Paris region of France have shown a switch from A and 
B1 strains to B2 strains.  These differences may well be due to the increased use of highly 
processed foods in French diets.  Similarly, another study examined the differences in 
the E. coli populations of residents of metropolitan France compared to expatriates that 
relocated from France to French Guyana (Skurnik et al., 2008).  The expatriates showed 
a lower prevalence of B2 strains compared to French residents.  This observation 
provides additional evidence that differences in diet result in differences in phylogroup 
abundance.  However, a limitation of all the studies examining the diversity of E. coli in 
humans is that the effects of climate cannot be completely separated from the effects 
of diet.  It may be that differences in survival in the external environment of strains 
belonging to the different phylogroups coupled with among-phylogroup differences in 
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transmission may explain the fact that B2 strains are less likely to be recovered from 
humans living in the tropics.  However, there is no evidence to indicate that there are 
climate dependent differences in survival or transmission (Unno et al., 2009).  Further, 
phylogenetic group B2 isolates were found be absent in human faecal samples collected 
in Jeonnam Province, South Korea, while phylogroup B2 strains were isolates from about 
50% of faecal samples collected from residents of Tokyo, Japan (Obata-Yasuoka et al., 
2002).  As both localities have a temperate climate, this suggests that diet difference 
may be responsible for the differences in phylogroup abundance among different 
geographic localities. 
 
Although differences in diet is the most likely explanation for the geographic variation 
in phylogroup abundance among humans, it is not known if diet exerts a direct effect, 
through the impact of diet, particularly fibre content and type, on gastro-intestinal 
transit times.  Studies in rats indicate that the cell densities of phylogroup B2 strains to 
respond to changes in the fraction of non-fermentable fibre in the diet (O’Brien & 
Gordon, 2011).  Another, non-mutually exclusive hypothesis, is that given it is well 
established that diet has a profound impact of the gut microbiota (Dore and Blottiere., 
2015), it may be changes in the interactions of E. coli with the gut microbiota that explain 
the geographic differences in phylogroup abundance of E. coli isolated from humans.  
Further research is required before we can understand what drives the geographic 
variation in phylogroup abundance. 
 
4.3 Within-host evolution 
Most the E. coli diversity observed in a human is a consequence of 
immigration/establishment events.  However, within host evolution did account for 
some of the observed diversity.  Although samples sizes are small, there was no 
indication that the probability of observing a strain whose presence was inferred to be 
a result of within host evolution varied with the phylogenetic group membership of the 
strain (Table 3.4).  The occurrence of within host evolution is not surprising given that 
there a numerous in vitro evolution studies of E. coli that show detectable variation can 
arise within a few generations (Kwon et al., 2015; Nisa et al., 2013), while within host 
variation has also been observed in vivo using a mouse model (Lescat et al., 2016; 
Batista-Barroso et al., 2014)   
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No patterns could be discerned in the nature of the differences between strains inferred 
to represent within host evolution events (Table 3.4).  The lack of pattern is perhaps not 
surprising given that the patients sampled were of different sexes, ages and gut disease 
states.   
 
In a study examining the extent of household sharing of ST131 E. coli strains (Johnson et 
al., 2016), showed that ST131 strains isolated from different members of the same 
household were consistently more similar to one another, than were ST131 isolates 
recovered from different households.  For 2 of the 6 households studied, within 
household variation was detected.  In one household, the father and daughter shared a 
ST131 strain that was different to the ST131 strain present in the mother.  In the other 
household, a mother and a child had indistinguishable isolates that differed from the 
ST131 isolate from the other child.  Such an outcome indicates that variants can arise 
within a host and spread to other household members. 
 
4.4 Measuring evolution of E. coli strains 
Reeves et al. (2011) characterised 14 isolates of ST73 recovered from a single family over 
3 years.  Using this data, they inferred a mutation rate of about 1.1 per genome per year.   
These data can be used to infer how long the strains representing within host evolution 
events may have persisted in their hosts.  Such an analysis would suggest that most 
strains had persisted in their hosts for 1.5-2.5 years, and one strain may have persisted 
for 11 years.  Although there are very little data available, published estimates indicate 
that strains may persist for at least 6 years within a host (Johnson et al., 2016).   Given 
that no study has monitored hosts for more than 6 years, much longer resident times 
may well be possible. 
 
Based on this study, it is clear when multiple strains belonging to the same phylogroup 
are present within a host, that independent immigration/establishment events are the 
explanation in about one half the observed cases.  Further, research is required to 
understand that what are the host/gut microbiota factors that select for strains 
belonging to particular phylogroups. 
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Appendix A. Age, sex and disease condition of the patients/hosts 
Patient Age Sex Disease condition 
1 56 F Normal 
3 29 F Normal 
4 49 F Crohn's disease 
5 18 F Ulcerative colitis 
6 44 F Ulcerative colitis 
7 47 F Crohn's disease 
8 62 M Crohn's disease 
9 73 M Normal 
10 54 M Normal 
11 69 M Normal 
12 61 M Normal 
13 43 F Crohn's disease 
14 18 F Normal 
15 35 M Normal 
16 53 F Normal 
17 31 F Crohn's disease 
18 21 M Normal 
19 26 F Crohn's disease 
20 40 F Crohn's disease 
21 71 M Ulcerative colitis 
22 26 M Crohn's disease 
23 50 F Normal 
24 43 F Normal 
25 24 M Crohn's disease 
26 26 F Crohn's disease 
27 23 M Ulcerative colitis 
28 40 M Crohn's disease 
29 23 M Ulcerative colitis 
30 29 M Ulcerative colitis 
32 24 M Ulcerative colitis 
33 53 M Crohn's disease 
35 51 F Crohn's disease 
36 49 M Crohn's disease 
37 47 F Normal 
39 28 F Crohn's disease 
40 52 F Crohn's disease 
41 65 F Crohn's disease 
42 22 M Crohn's disease 
43 24 M Crohn's disease 
44 61 M Crohn's disease 
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Patient Age Sex Disease condition 
45 33 F Crohn's disease 
46 30 M Ulcerative colitis 
47 44 F Crohn's disease 
48 44 F Crohn's disease 
50 41 F Crohn's disease 
51 61 M Ulcerative colitis 
52 29 F Normal 
53 23 M Crohn's disease 
54 33 F Crohn's disease 
55 34 F Crohn's disease 
56 38 M Normal 
57 50 M Crohn's disease 
58 55 M Ulcerative colitis 
59 45 F Ulcerative colitis 
60 32 F Ulcerative colitis 
61 45 F Ulcerative colitis 
62 24 M Normal 
63 43 M Ulcerative colitis 
65 50 M Normal 
66 62 M Crohn's disease 
67 49 M Crohn's disease 
68 38 F Ulcerative colitis 
69 20 M Crohn's disease 
70 21 M Crohn's disease 
71 24 M Normal 
72 52 M Ulcerative colitis 
73 53 F Ulcerative colitis 
 
F=Female, M=Male 
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Appendix B. Whole genome sequence assembly data for the isolates examined for this study. Isolates 
depicted in red text were sequenced on the Illumina HiSeq2000 platform, whilst all other were sequenced 
on the Illumina MiSeq platform. 
No. Patient Isolate Phylogroup A5-MiSeq assembly 
N50 Contig Total Base Coverage 
1 1 1_3_Ti10 D 40,543 258 4,848,126 23 
2 1_2_C20 B2 102,381 100 4905153 52 
3 3 3_1_AU1 A 71,343 243 4,842,799 45 
4 4 4_1_C3 D 46,082 281 5,292,241 31 
5 4_2_Ti8 D 38,848 310 5,282,957 22 
6 5 5_2_R8 B2 64,647 203 5,078,904 31 
7 5_1_TC12 B2 56,976 192 5,063,162 39 
8 6 6_1_TC16 B2 42,097 234 5,049,116 28 
9 7 7_3_R4 D 37,681 263 4,795,263 28 
10 8 8_1_AC8 D 53,688 302 5,440,995 59 
11 8_3_DC15 B1 17,008 582 4,889,738 22 
12 8_3_Ti3 B1 19,685 552 4,780,896 24 
13 8_2_Ti16 A 40,062 327 5,184,649 30 
14 8_5_Ti14 A 37,591 292 5,194,050 47 
15 9 9_5_R1 B2 41630 256 4,844,129 29 
16 10 10_1_R6 B2 37,213 250 4,876,877 31 
17 11 11_1_Ti6 D 43,101 273 5,167,698 39 
18 12 12_1_Ti12 B2 55,659 236 5,031,202 61 
19 12_2_Ti13 B2 230,154 134 5,059,420 97 
20 13 13_1_C11 B2 67,477 152 4,817,117 36 
21 13_2_TC5 B2 58,720 176 4,813,537 34 
22 13_3_TC6 B2 78,315 132 4,821,721 38 
23 14 14_1_R13 D 52,243 227 4,952,112 33 
24 14_2_R14 D 51,128 223 4,952,506 32 
25 14_4_DC7 D 48,473 252 4,953,021 37 
26 15 15_5_C3 B2 76,546 138 4,880,231 53 
27 15_7_TC2 B2 48,434 203 4,861,650 34 
28 16 16_1_Ti5 A 35,267 280 4,672,403 39 
29 16_2_Si18 A 56,783 222 4,696,778 80 
30 16_3_C13 A 41,632 229 4,684,519 41 
31 16_4_Ti11 A 38,233 264 4,673,369 36 
32 16_5_Ti20 A 27,530 332 4,661,094 30 
33 17 17_1_R20 F 71,132 277 5,135,433 100 
34 17_2_DC14 F 35,374 303 5,160,775 39 
35 18 18_1_DC10 B1 26,030 416 4,644,121 17 
36 18_2_AC4 B1 71,927 182 4,936,830 45 
37 18_3_Ti5 B2 243,933 195 5,177,796 54 
38 18_4_Ti12 B2 296,258 188 5,177,995 80 
39 18_3_AC5 B2 37,719 267 5,134,046 34 
40 19 19_1_TC4 B2 195,371 205 5,279,579 96 
41 19_1_Ti7 B2 284,439 182 5,278,381 78 
42 19_2_TC6 B2 252,687 187 5,278,831 98 
43 19_2_Ti6 B2 74,789 664 5,326,926 105 
44 19_3_TC2 B2 33,537 361 5,207,366 36 
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No. Patient Strain  Phylogroup A5-MiSeq assembly 
  N50 Contig Total Base Coverage 
45 20 20_1_TC6 B1 67,633 191 4,804,197 55 
46 20_2_TC13 B1 122,165 94 4,813,879 57 
47 20_3_TC12 B1 114,619 123 4,820,185 65 
48 20_5_R7 B2 123,680 149 5,341,929 40 
49 21 21_1_TC7 B2 94,461 185 5,340,017 56 
50 21_2_C8 B2 89,776 190 5,378,635 39 
51 22 22_1_Ti17 D 95,206 213 4,981,075 96 
52 22_1_Ti19 D 116,528 190 4,990,216 62 
53 22_4_Ti18 D 153,839 169 4,989,495 67 
54 22_3_TiNA12 D 61,909 198 4,966,843 37 
55 23 23_1_TC4 B2 83,279 178 5,140,481 58 
56 23_2_AC12 B2 60,124 207 5,134,047 48 
57 23_2_Ti8 B2 48,193 251 5,113,119 26 
58 23_3_Ti9 B2 86,000 164 5,139,149 58 
59 23_4_R13 B2 84,833 208 5,378,189 39 
60 24 24_1_Si1 B1 40,419 294 4,939,825 36 
61 24_4_R6 B2 74,152 124 4,781,365 30 
62 25 25_1_ADC_2 D 282,422 176 5,012,613 111 
63 25_2_DC7 D 65,034 206 5,144,741 36 
64 25_3_ADC_20 D 120,600 210 5,126,546 93 
65 25_5_NDC20 D 60,092 208 5,108,851 41 
66 26 26_1_C13 D 63,604 197 5,087,333 33 
67 26_2_C12 D 55,007 191 5102409 39 
68 27 27_1_R1 B2 123,984 102 5,123,424 49 
69 29 29_1_DC3 D 85,983 186 5,222,806 31 
70 29_4_DC8 D 65,610 210 5,221,413 38 
71 29_2_DC4 B2 94,580 159 5,105,439 38 
72 29_3_DC10 B1 64,809 198 5,080,582 45 
73 30 30_1_R8 F 169,716 282 5,199,822 40 
74 30_2_R7 F 64,655 179 5,204,538 41 
75 32 32_1_DC18 B2 115,451 101 5,112,526 49 
76 32_2_R12 B2 94,553 148 4,980,173 59 
77 33 33_1_TC19 B2 200,666 238 4,987,863 53 
78 33_1_Ti5 B2 88,880 204 4,936,419 47 
79 33_2_AC11 B2 94,936 132 4,963,667 45 
80 33_3_R3 B1 102,978 120 4,874,489 58 
81 35 35_9_Ti14 B2 117,484 140 5,036,235 63 
82 36 36_1_TC9 B2 114,927 232 5,043,258 47 
83 36_1_Ti13 B2 135,729 181 5,040,730 46 
84 37 37_2_AC20 B1 41,646 275 4,938,192 28 
85 39 39_1_AC10 B2 88,788 131 5,042,263 72 
86 39_2_Ti18 B2 234,240 464 5,246,578 70 
87 40 40_1_R9 B2 95,952 109 5,045,005 65 
88 40_3_R7 B2 63,667 159 5,030,684 54 
89 41 41_1_Ti9 D 190,932 184 5,044,437 46 
90 41_2_Ti13 D 195,608 178  73 
91 42 42_1_R2 A 36,883 285 4,741,567 32 
 
 
46 
 
No. Patient Strain  Phylogroup A5-MiSeq assembly 
  N50 Contig Total Bases Coverage 
92 43 43_1_R3 B1 82,187 141 4,857,182 53 
93 
 
43_4_AC3 B1 158,385 73 4,854,991 59 
94   43_2_R17 B1 49,515 202 4,715,835 58 
95 44 44_1_Ti4 B1 87,815 172 5,063,032 66 
96 
 
44_2_Ti11 B1 56,705 237 5,052,644 48 
97   44_4_Ti15 B1 114,847 119 5,066,322 49 
98 45 45_1_Ti1 B2 146,037 77 5,165,457 58 
99 
 
45_1_HU2 B2 132,312 97 5,146,349 48 
100 
 
45_3_DC2 B2 114,683 194 5,245,570 42 
101 
 
45_2_HU10 A 153,160 82 4,850,289 68 
102   45_7_HU9 A 92,985 122 4,846,243 58 
103 46 46_1_Ti2 B2 358,431 169 5,196,628 78 
104 46_2_Ti11 D 107,383 157 5,497,384 46 
105 47 47_1_TC4 D 297,445 50 5,007,897 61 
106 47_3_R4 B1 211,746 60 4,716,540 69 
107 47_4_R1 D 311,185 61 4,979,043 71 
108 48 48_1_R18 B2 339,742 44 5,060,992 76 
109 48_5_R19 B2 160,035 79 5,056,070 49 
110 50 50_4_ACUA1 B1 86,584 146 4,715,153 48 
111 
 
50_5_TCA1 B1 77,074 150 4,707,995 40 
112 
 
50_6_TCUA1 A 96,473 119 4,772,242 60 
113   50_7_TCUA2 B1 27,450 316 4,619,496 16 
114 51 51_1_Ti1 B1 197,462 62 4,795,944 67 
115 51_2_R1 D 138,644 109 4,951,732 82 
116 51_3_R19 D 180,933 90 4,948,446 92 
117 51_6_R16 D 134,447 102 4,946,004 71 
118 51_7_R18 D 104,075 134 4,943,858 72 
119 52 52_1_Ti3 B2 242,632 193 5,184,535 92 
120 52_2_Ti10 B2 219,999 237 5,110,524 101 
121 53 53_1_AC6 B1 84,028 170 5,062,473 65 
122 53_1_AUC1 B1 134,422 217 5,025,882 66 
123 54 54_1_TC4 B2 553,572 88 4,735,371 26 
124 54_1_Ti6 B2 653,360 127 4,745,605 121 
125 55 55_1_TC9 B2 355,821 103 5,066,056 41 
126 55_1_Ti19 B2 222,239 102 5,068,252 80 
127 56 56_1_TC1 D 178,338 628 5,031,763 126 
128 56_1_AC4 D 106,670 125 4,955,127 62 
129 56_3_AC1 D 133,916 103 4,969,730 92 
130 56_4_R1 D 139,738 90 4,976,326 85 
131 56_2_AC5 B2 287,062 66 5,279,666 98 
132 57 57_2_DC4 A 86,839 122 4,750,008 91 
133 57_3_TC14 B2 168,969 96 4,791,137 72 
134 57_3_Ti5 B2 407,054 65 4,784,593 110 
135 57_5_R8 B2 207,989 62 4,795,833 83 
136 58 58_2_AC1 B2 167,308 67 4,937,919 95 
137 58_3_Ti7 A 73,351 195 4,963,826 60 
138 59 59_1_AC3 A 70,024 211 5,025,537 79 
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No. Patient Strain  Phylogroup A5-MiSeq assembly 
  N50 Contig Total Bases Coverage 
139 60 60_1_Ti1 B2 429,061 192 5,111,750 78 
140 61 61_1_Ti1 B2 245,678 206 5,156,131 61 
141   61_2_AC9 B2 146,570 122 5,194,656 68 
142 62 62_1_Ti3 B2 371,257 114 5,139,135 100 
143 
 
62_2_Ti6b B2 102,671 138 5,280,469 82 
144   62_4_Si7 B1 110,472 87 4,794,083 78 
145 63 63_1_Ti1 D 183,569 259 5,410,738 115 
146   63_2_TC7 B2 66,633 197 5,096,291 26 
147 65 65_2_AC1 A 57,830 246 5,227,319 25 
148 
 
65_1_AC2 D 47,226 241 5,396,222 23 
149 
 
65_3_TC1 D 35,971 364 5,406,787 32 
150   65_4_AC20 D 121,976 313 5,469,320 46 
151 66 66_1_AC1 D 46,650 232 4,821,959 51 
152 67 67_1_Ti13 D 49,694 224 4,856,957 31 
153 67_3_Ti10 D 37,367 365 5,009,246 32 
154 67_4_Ti7 A 57,737 213 4,971,306 57 
155 68 68_2_Ti3 B1 41,496 256 4,890,156 40 
156 68_4_TC14 B1 48,403 216 4,903,793 48 
157 68_3_TC19 D 39,140 271 4,844,304 36 
158 69 69_1_TC1 B2 58,220 222 4,859,241 56 
159 69_1_Ti1 B2 662,554 69 4,859,586 50 
160 69_2_R20 B2 148,853 94 4,851,418 47 
161 70 70_1_AC3 D 48,361 281 5,468,183 18 
162 
 
70_2_TC2 D 152,551 232 5,349,949 29 
163 
 
70_4_DC20 B2 120,032 120 5,164,165 26 
164 
 
70_5_R4 B2 164,456 86 5,167,164 44 
165 
 
70_2_Ti12 B2 226,521 95 4,860,391 60 
166   70_3_Ti8 D 83,335 155 4,879,233 29 
167 71 71_1_AC1 F 73,839 329 5,032,284 64 
168   71_2_Ti5 D 163,406 85 4,929,344 41 
169 72 72_2_AC9 B2 84,746 192 5,318,366 26 
170 72_3_TC1 B2 34,270 372 5,249,600 15 
171 72_4_Ti9 D 32,808 308 4,933,577 19 
172 72_5_Ti14 D 54,421 202 4,915,331 41 
173 72_6_Ti12 B2 654,244 76 4,861,457 45 
174 73 73_1_Si1 B1 58,250 185 4,797,691 50 
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Appendix C: Two independent culture of the same strain of 19 samples were sequenced twice and used to find the SNPs between same strains.  
 
 
 
No. Strain Phylogroup Source A5-MiSeq assembly 
N50 Contig Total Bases Coverage 
1  B271_GS F Bird faecal 22,665 271 5,083,106 11 
2 B271_S26 153,908 139 5,543,208 35 
3 B1549_00 F Bird faecal 179,247 154 5,028,093 93 
4 B1549_S36 153,815 100 5,049,875 41 
5 W3_62_S12 A Chicken 78,252 265 5,677,890 33 
6 W3_62_S18 84,079 285 5,669,305 40 
7 B313_S6 B1 Bird faecal 123,956 127 4,884,560 28 
8 B313_S7 85,252 150 4,897,531 41 
9 5_1_TC12 B2 Biopsy 56,976 192 5,063,162 39 
10 5_1_TC12_redo 82,264 176 5,097,831 45 
11 8_2_Ti16 A Biopsy 40,062 327 5,184,649 30 
12 8_2_Ti16_redo 54,647 271 5,245,475 33 
13 8_3_Ti3 B1 Biopsy 19,685 552 4,780,896 24 
14 8_3_Ti3_redo 19,703 515 4,860,462 33 
15 B1932_GS F Bird faecal 185,361 330 5,161,503 65 
16 B1932_S46 58,361 213 5,087,931 21 
17 DMG_G1_S33 B2 Human faecal 44,169 232 4,827,400 40 
18 DMG_G1_S38  84,641 153 4,884,184 67 
19 DMG_G2_S34 B2 Human faecal 52,336 220 4,843,190 42 
20 DMG_G2_S39 45,838 214 4,851,614 50 
21 DMG_G3_S35 B2 Human faecal 71,636 163 4,878,271 67 
22 DMG_G3_S40 57,055 187 4,856,587 45 
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23 H173_GS C Human faecal 173,372 144 4,961,583 58 
24 H173_S13 222,627 90 4,987,478 73 
25 H440_GS A Human Blood 198,974 119 4,914,984 59 
26 H440_S14 56,160 226 4,856,469 37 
27 E2845_S33 B1 Water 155,561 72 4,891,149 32 
28 E2845_S48 84,824 133 4,848,136 23 
29 M1213_GS E Dasyurus maculatus faecal 121,977 1144 5,748,607 57 
30 M1213_S22 89,086 260 5,646,787 25 
31 18_1_DC10 B1 Biopsy 26,030 416 4,644,121 17 
32 18_1_DC10_redo 69,005 203 4,936,579 44 
33 A1_66_S14 B2 Chicken meat 93,185 142 5,291,666 32 
34 A1_66_S44 164,260 88 5,330,677 48 
35 B1858_GS F Bird faecal 344,604 104 4,946,847 47 
36 B1858_S45 89,136 148 4,890,104 26 
37 W1_57_S13 B2 Chicken meat 156,811 104 5,232,396 38 
38 W1_57_S27 133,412 92 5,239,979 38 
 
